An enzyme immunoassay for polymorphonuclear leucocyte-mediated fibrinogenolysis

European Journal of Clinical Investigation

Volumn 27, Issue 2, 1997, Pages 148-156

  Bos, R ^a   Van Leuven, C J M ^a   Stolk, J ^b   Hiemstra, P S ^b   Ronday, H K ^b   Nieuwenhuizen, W ^a  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

elastase; enzyme immunoassay; fibrinogen; monoclonal antibody; polymorphonuclear leucocytes; pulmonary emphysema; rheumatoid arthritis

Indexed keywords

BIOCHEMICAL MARKER; ELASTASE; FIBRINOGEN; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LUNG EMPHYSEMA; MALE; MONITORING; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN DEGRADATION; RHEUMATOID ARTHRITIS; SEPSIS;

EID: 0031055390     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.810634.x     Document Type: Article

References (34)

1. Janoff A. Elastases and emphysema: current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis 1985;132:417-33.
2. Ogushi F, Hubbard RC, Vogelmeier C, Fells GA, Crystal RG, Risk factors for emphysema: cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase. J Clin Invest 1991;87:1060-5.
3. Fera T, Abboud RT, Richter A, Johal SS. Acute effect of smoking on elastase-like esterase activity and immunologic neutrophil elastase levels in bronchoalveolar lavage fluid. Am Rev Respir Dis 1986;129:569-73.
4. Bercher AS, Thevananther S, Franco-Saenz R. Acetaldehyde inhibits the anti-elastase activity of α 1-antitrypsin. Alcohol 1994; 11:181-5.
5. Laurell CB, Eriksson S. The electrophoretic alpha-1-globulin pattern of serum in alpha-1 antitrypsin deficiency. Scand J Clin Lab Invest 1963;15:132-40.
6. Starchier B, Williams I. The beige mouse: role of neutrophil elastase in the development of pulmonary emphysema. Exp Lung Res 1989;15:785-800.
7. Stolk J, Rudolphus A, Davies P et al. Induction of emphysema and bronchial mucus cell hyperplasia by intratracheal instillation of lipopolysaccharide in the hamster. J Pathol 1992;167:349-56.
8. Philippé J, Dooijewaard G, Offner F, Turion P, Baele G, Leroux-Roels G. Granulocyte elastase, tumor necrosis factor-α and urokinase levels as prognostic markers in severe infection. Thromb Haemost 1992;68:19-23.
9. O'Connor CM, Gaffney K, Keane J, Southey A, Byme N, O'Mahoney S, Fitzgerald MX. α1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis. Am Rev Respir Dis 1993;148:1665-70.
10. Frette C, Jacob M-P, Kauffmann F. Plasma elastin peptide level, a diagnostic test for chronic obstructive lung disease. Am Rev Respir Dis 1993;147:1063-4.
11. Pelham F, Wewers M, Crystal R, Sonia Buist A, Janoff A. Urinary excretion of desmosine (elastin cross-links) in subjects with PiZZ alpha-1-antitrypsin deficiency. Am Rev Respir Dis 1985;132:821-3.
12. Weitz JI, Landman SL, Crowley KA, Birken S, Morgan FJ, Development of an assay for in vivo neutrophil elastase activity. Increased elastase activity in patients with α1-proteinase inhibitor deficiency. J Clin Invest 1986;78:155-68.
13. Wallin R, Saldeen T. A specific radioimmunoassay for determination of peptides derived from elastase degradation of human fibrin (ogen). Acta Univ Upsaliensis 1987;102:1-26.
14. Carmassi F, De Negri F, Morale M, Puccetti R, Song KY, Chung SI. Assessment of coagulation and fibrinolysis in synovial fluid of rheumatoid arthritis patients. Fibrinolysis 1994;8:162-71.
15. Dinerman JL, Mehta JL, Saldeen TPG, Emerson S, Wallin R, Davda R, Davidson A. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Coll Cardiol 1990;15:1559-63.
16. Bos R, van Leuven CJM, Stolk J, Hiemstra PS, Dijkman JH, Nieuwenhuizen W. A monoclonal antibody with high affinity for a neo-antigenic site in fibrinogen degraded by polymorphonuclear leukocyte-derived elastase. Blood Coagulation Fibrinolysis 1995; 66:259-67.
17. Koppert PW, Koopman J, Haverkate F, Nieuwenhuizen W. Production and characterisation of a monoclonal antibody reactive with a specific neoantigenic determinant (comprising Bβ 54-118) in degradation products of fibrin and of fibrinogen. Blood 1986;2:437-41.
18. Van Ruijven-Vermeer IAM, Nieuwenhuizen W. Purification of rat fibrinogen and its constituent chains. Biochem J 1978;169:653-9.
19. Feinstein G, Janoff A. A rapid method for the purification of human granulocyte cationic neutral proteases: purification and further characterization of human granulocyte elastase. Biochim Biophys Acta 1975;403:493-505.
20. Feinstein G, Janoff A, A rapid method for purification of human granulocyte cationic neutral proteases: purification and characterization of human granulocyte chymotrypsin-like enzyme. Biochim Biophys Acta 1975;403:477-92.
21. Koppert PW, Hoegee-de Nobel E, Nieuwenhuizen W. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma. Thromb Haemost 1988;59:310-5.
22. Sterrenberg L, Blonk A, van Liempt GJ, Hermans J, Nieuwenhuizen W. Purification and properties of early (X-like) and late (D-like) fibrinogen fragments, produced by leukocyte elastase. In: Haverkate F, Menschen A, Nieuwenhuizen W, Straub PW, eds. Fibrinogen, Structure, Functional Aspects, Metabolism. Berlin: Walter de Gruyter, 1983:235-53.
23. Koppert PW, Kuipers W, Hoegee-de Nobel B, Brommer EJP, Koopman J, Nieuwenhuizen W. A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma. Thromb Haemost 1987;57:25-8.
24. Koopman J, Haverkate F, Koppert P, Nieuwenhuizen W, Brommer EJP, Van Der Werf WGC. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody. J Lab Clin Med 1987;109:75-84.
25. Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage T4′. Nature 1970;227:680-5.
26. De Boer M, Roos D. Purification and cryopreservation of phagocytes from human blood. Methods Enzymol 1986;132:225-30.
27. Hanlon WA, Stolk J, Davies P, Humes JL, Mumford R, Bonney RJ. rTNFα facilitates human polymorphonuclear leukocyte adherence to fibrinogen matrices with mobilization of specific and tertiary but not azurophilic granule markers. J Leukocyte Biol 1991;50:43-8.
28. Diamond MS, Springer TA. A subpopulation of Mac-1 (CD11b/ CD 18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J Cell Biol 1993;120:545-56.
29. De Bruin PAF, Verspaget HW, Griffioen G, Nap M, Verheijen JH, Lamers CBHW. Plasminogen activator activity and composition in human colorectal carcinomas. Fibrinolysis 1989;1:57-62.
30. Barret AJ. Introduction to the history and classification of tissue proteinases. In: Barrett AJ, ed. Proteinases in Mammalian Cells and Tissues. Amsterdam: North-Holland Publishing 1977:1-55.
31. Werb Z, Alexander CM. Proteinases and matrix degradation. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of Rheumatology, 4th edn. Philadelphia: WB Saunders, 1993:248-268.
32. Nieuwenhuizen W, Vermond A, Hermans J. Human fibrinogen binds EDTA and citrate. Thromb Res 1981;22:659-63.
33. Haverkate F, Timan G. Protective effect of calcium in the plasmin degradation of fibrinogen and fibrin fragments D. Thromb Res 1977;10:803-12.
34. Nieuwenhuizen W, Vermond A, Haverkate F. Factors influencing the structure of terminal plasmin degradation products of human fibrinogen and fibrin. Biochim Biophys Acta 1981;667:321-7.